Diabetes Care. 2025 Apr 3:dc242478. doi: 10.2337/dc24-2478. Online ahead of print.ABSTRACTOBJECTIVE: This study evaluated the incremental predictive value of proteomic biomarkers in assessing 10-year type 2 diabetes risk when added to the clinical Cambridge Diabetes Risk Score (CDRS).RESEARCH DESIGN
Diabetes Care. 2025 Apr 2:dc242494. doi: 10.2337/dc24-2494. Online ahead of print.ABSTRACTOBJECTIVE: The glucose management indicator (GMI) is widely used as a replacement for HbA1c, but information in pregnancy is very limited. We assessed the accuracy of GMI and associations with pregnancy outcome
Diabetes Care. 2025 Apr 2:dc242169. doi: 10.2337/dc24-2169. Online ahead of print.ABSTRACTOBJECTIVE: Anticipated risks of urinary tract infections (UTI) and genital tract infections (GTI) associated with sodium-glucose cotransporter 2 inhibitors (SGLT2i) may prevent their use in clinical practice. W
Diabetes Care. 2025 Apr 2:dc242519. doi: 10.2337/dc24-2519. Online ahead of print.ABSTRACTOBJECTIVE: To assess the concordance between serum creatinine (SCr)- and serum cystatin C (SCysC)-based estimated glomerular filtration rate (eGFR) in individuals with type 1 diabetes (T1D) at different stages
Diabetes Care. 2025 Mar 31:dc241972. doi: 10.2337/dc24-1972. Online ahead of print.ABSTRACTOBJECTIVE: The Diabetes in Children, Adolescents, and Young Adults (DiCAYA) network seeks to create a nationwide electronic health record (EHR)-based diabetes surveillance system. This study aimed to develop a
Diabetes Care. 2025 Mar 31:dc242748. doi: 10.2337/dc24-2748. Online ahead of print.ABSTRACTOBJECTIVE: To evaluate the effectiveness of community-based peer support for diabetes self-management with HbA1c and other clinical and psychosocial outcomes over 24 months.RESEARCH DESIGN AND METHODS: This st
Diabetes Care. 2025 Mar 31:dc242614. doi: 10.2337/dc24-2614. Online ahead of print.ABSTRACTOBJECTIVE: To test the association of autonomic nervous system (ANS) dysregulation symptoms and diabetes distress (DD) in adults with type 1 diabetes (T1D; study 1) and type 2 diabetes (T2D; study 2).RESEARCH
Diabetes Care. 2025 Mar 31:dc242431. doi: 10.2337/dc24-2431. Online ahead of print.ABSTRACTOBJECTIVE: Despite established relationships between glycemia and cognition, few studies have evaluated within-person changes over time. We paired continuous glucose monitoring (CGM) with ambulatory cognitive
Diabetes Care. 2025 Mar 29:dc250241. doi: 10.2337/dc25-0241. Online ahead of print.ABSTRACTBACKGROUND: Glucagon-like peptide 1 receptor agonists (GLP-1RA) reduce the incidence of major adverse cardiovascular events (MACE) in type 2 diabetes (T2D), although whether benefits extend to both subcutaneou
Diabetes Care. 2025 Mar 25:dc242532. doi: 10.2337/dc24-2532. Online ahead of print.ABSTRACTOBJECTIVE: Preclinical studies in animals have suggested potential neuroprotective effects of sodium-glucose cotransporter 2 inhibitors (SGLT-2is), but no epidemiological study has investigated the potential e
No abstractDiabetes Care. 2025 Apr 1;48(4):e61-e62. doi: 10.2337/dci24-0109.NO ABSTRACTPMID:40117475 | DOI:10.2337/dci24-0109
No abstractDiabetes Care. 2025 Apr 1;48(4):e58-e59. doi: 10.2337/dc24-2705.NO ABSTRACTPMID:40117474 | DOI:10.2337/dc24-2705
Diabetes Care. 2025 Apr 1;48(4):499-508. doi: 10.2337/dci24-0047.ABSTRACTThe Norbert Freinkel Award recognizes contribution of research, clinical practice, and advocacy to improving pregnancy outcomes for women with diabetes. This award honors a man of outstanding achievements. Norbert was a forward
No abstractDiabetes Care. 2025 Apr 1;48(4):e60. doi: 10.2337/dc24-2720.NO ABSTRACTPMID:40117471 | PMC:PMC11932808 | DOI:10.2337/dc24-2720
No abstractDiabetes Care. 2025 Apr 1;48(4):e63-e64. doi: 10.2337/dc24-2847.NO ABSTRACTPMID:40117470 | DOI:10.2337/dc24-2847
No abstractDiabetes Care. 2025 Apr 1;48(4):496. doi: 10.2337/dci25-0018.NO ABSTRACTPMID:40117469 | DOI:10.2337/dci25-0018
No abstractDiabetes Care. 2025 Apr 1;48(4):e56. doi: 10.2337/dc24-2133.NO ABSTRACTPMID:40117467 | PMC:PMC11932805 | DOI:10.2337/dc24-2133
Diabetes Care. 2025 Apr 1;48(4):655-664. doi: 10.2337/dc24-2510.ABSTRACTBACKGROUND: Inpatient hyperglycemia is common among adults, and management varies.PURPOSE: To systematically identify guidelines on inpatient hyperglycemia management.DATA SOURCES: MEDLINE, Guidelines International Network, and
No abstractDiabetes Care. 2025 Apr 1;48(4):e57. doi: 10.2337/dci24-0089.NO ABSTRACTPMID:40117465 | DOI:10.2337/dci24-0089
Diabetes Care. 2025 Mar 21:dc242535. doi: 10.2337/dc24-2535. Online ahead of print.ABSTRACTOBJECTIVE: To explore the association between diabetes and anemia.RESEARCH DESIGN AND METHODS: We included 9,026 and 389,616 participants from the U.S. National Health and Nutrition Examination Surveys and the
Diabetes Care. 2025 Mar 21:dci240104. doi: 10.2337/dci24-0104. Online ahead of print.ABSTRACTInsulin deficiency, often aggravated by insulin resistance, results in type 2 diabetes mellitus (T2DM). With the availability of glucagon-like peptide 1 receptor agonists and sodium-glucose cotransporter 2 i
Diabetes Care. 2025 Mar 18:dc242790. doi: 10.2337/dc24-2790. Online ahead of print.ABSTRACTOBJECTIVE: To evaluate late (week 40 or 42; hereafter, week 40/42) metabolic outcomes by early glycemic response (<20% or ≥20% fasting serum glucose [FSG] reduction at week 4) or weight response (<5% or ≥5% we
No abstractDiabetes Care. 2025 Mar 18:dc242840. doi: 10.2337/dc24-2840. Online ahead of print.NO ABSTRACTPMID:40100966 | DOI:10.2337/dc24-2840
No abstractDiabetes Care. 2025 Mar 17:dc250058. doi: 10.2337/dc25-0058. Online ahead of print.NO ABSTRACTPMID:40096546 | DOI:10.2337/dc25-0058
